HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anecortave (Alcon Laboratories).

Abstract
Anecortave, an angiostatic steroid administered as a posterior juxtascleral depot, is under development by Alcon Laboratories Inc for the potential prevention and treatment of ocular diseases, in particular age-related macular degeneration.
AuthorsStanely A Vinores
JournalIDrugs : the investigational drugs journal (IDrugs) Vol. 8 Issue 4 Pg. 327-34 (Apr 2005) ISSN: 1369-7056 [Print] England
PMID15800808 (Publication Type: Journal Article, Review)
Chemical References
  • Angiogenesis Inhibitors
  • Drugs, Investigational
  • Pregnadienediols
  • anecortave acetate
Topics
  • Angiogenesis Inhibitors (chemistry, therapeutic use)
  • Animals
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase III as Topic
  • Drug Industry (legislation & jurisprudence, methods)
  • Drugs, Investigational (chemistry, therapeutic use)
  • Humans
  • Pregnadienediols (chemistry, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: